You are here: Industry Insights > DNA

News List

Genomic sequencing is a potential key to precision medicine for cancer europeanpharmaceuticalreview
July 29, 2021
A new US study demonstrated that comprehensive genomic sequencing is crucial for the development of precision medicine for cancer patients.
Ring Therapeutics Raises $117 Million in Series B Funding to Expand Novel Vector Platform to Unlock the Full Potential of Gene Therapy firstwordpharma
July 29, 2021
Ring's novel vector Anellogy™ platform harnesses unique properties of anelloviruses to create a pipeline of redosable vectors compatible with the human immune system to target specific tissues
OriCiro Announces ¥1 Billion Series B Financing to Advance Cell-Free DNA Technology for Innovative Therapeutics and Synthetic Biology prnasia
July 21, 2021
OriCiro Genomics announced that it has raised ¥800 million in Series B financing led by The University of Tokyo Edge Capital Partners (UTEC) with participation of ITOCHU Technology Ventures (ITV).
Thermo Fisher Scientific Opens New Plasmid DNA Manufacturing Facility contractpharma
July 16, 2021
Thermo Fisher Scientific Inc. has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines.
Could a DNA Blood Test Spot a Range of Hidden Cancers? drugs
June 28, 2021
Could a new one-and-done blood test designed to detect as many as 50 different types of cancer become a diagnostic game changer?
Mina J. Bissell Ph.D. & Vectorspace AI Advance New Space Biosciences Division prnasia
June 23, 2021
As the new space race heats up, more humans will be traveling into space than ever before. Spaceflight causes many changes in human health.
Cyteir Therapeutics Announces Closing of Initial Public Offering firstwordpharma
June 23, 2021
Cyteir Therapeutics, Inc. today announced the closing of its initial public offering of 7,400,000 shares of its common stock at an initial public offering price of $18.00 per share.
DNA production specialist Touchlight raises £42m pharmatimes
March 12, 2021
Hampton, UK-based biotech company Touchlight has raised £42m in its latest fundraising round, led by Bridford Investments Limited.
DECODR app identifies unintentional DNA mutations from CRISPR gene therapies europeanpharmaceuticalreview
February 24, 2021
The DECODR app was developed to accelerate the development of CRISPR gene therapies, producing similar data as deep sequencing processes in a shorter timeframe and at less cost.
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities contractpharma
December 18, 2020
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.

Previous page 1 2 3 4 5 6 7 8 9 Next page